IFG Advisory’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $430K | Buy |
2,663
+343
| +15% | +$55.3K | 0.02% | 499 |
|
2025
Q1 | $395K | Buy |
2,320
+6
| +0.3% | +$1.02K | 0.02% | 488 |
|
2024
Q4 | $385K | Buy |
+2,314
| New | +$385K | 0.02% | 477 |
|
2024
Q3 | – | Sell |
-2,295
| Closed | -$353K | – | 456 |
|
2024
Q2 | $353K | Buy |
+2,295
| New | +$353K | 0.02% | 471 |
|
2024
Q1 | – | Sell |
-2,762
| Closed | -$437K | – | 433 |
|
2023
Q4 | $437K | Sell |
2,762
-331
| -11% | -$52.3K | 0.03% | 385 |
|
2023
Q3 | $453K | Buy |
+3,093
| New | +$453K | 0.04% | 361 |
|
2023
Q2 | – | Sell |
-3,767
| Closed | -$584K | – | 371 |
|
2023
Q1 | $584K | Sell |
3,767
-1,090
| -22% | -$169K | 0.05% | 290 |
|
2022
Q4 | $748K | Buy |
4,857
+2,527
| +108% | +$389K | 0.07% | 248 |
|
2022
Q3 | $307K | Buy |
2,330
+143
| +7% | +$18.8K | 0.03% | 410 |
|
2022
Q2 | $298K | Sell |
2,187
-1,340
| -38% | -$183K | 0.03% | 381 |
|
2022
Q1 | $526K | Sell |
3,527
-2,608
| -43% | -$389K | 0.05% | 300 |
|
2021
Q4 | $993K | Buy |
6,135
+397
| +7% | +$64.3K | 0.1% | 203 |
|
2021
Q3 | $952K | Buy |
5,738
+323
| +6% | +$53.6K | 0.1% | 201 |
|
2021
Q2 | $934K | Sell |
5,415
-665
| -11% | -$115K | 0.1% | 207 |
|
2021
Q1 | $975K | Sell |
6,080
-1,818
| -23% | -$292K | 0.12% | 190 |
|
2020
Q4 | $1.33M | Buy |
7,898
+729
| +10% | +$122K | 0.18% | 140 |
|
2020
Q3 | $1.13M | Buy |
7,169
+1,601
| +29% | +$252K | 0.18% | 131 |
|
2020
Q2 | $934K | Buy |
5,568
+1,777
| +47% | +$298K | 0.17% | 144 |
|
2020
Q1 | $497K | Buy |
3,791
+66
| +2% | +$8.65K | 0.11% | 193 |
|
2019
Q4 | $553K | Sell |
3,725
-311
| -8% | -$46.2K | 0.1% | 217 |
|
2019
Q3 | $499K | Buy |
+4,036
| New | +$499K | 0.1% | 233 |
|